Action of dopamine on the human iris.
D000328:Adult; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004106:Dilatation; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D006801:Humans; D007024:Hypotension, Orthostatic / Q000209:etiology; D007498:Iris / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009411:Nerve Endings / Q000187:drug effects; D009638:Norepinephrine / Q000096:biosynthesis / Q000378:metabolism; D009883:Ophthalmic Solutions / Q000494:pharmacology; D010300:Parkinson Disease / Q000188:drug therapy; D011955:Receptors, Drug; D013564:Sympathetic Nervous System / Q000187:drug effects
D018492:Dopamine Antagonists; D009883:Ophthalmic Solutions; D011955:Receptors, Drug; D004295:Dihydroxyphenylalanine; D004298:Dopamine; D009638:Norepinephrine; D006145:Guanethidine